Nariman Nasser

Nariman Nasser has a diverse work experience spanning various roles in the pharmaceutical and clinical research industry. Starting in 2000, Nasser worked as a Project Coordinator at Caspian Consulting until 2004. In 2004, Nasser joined Biomarin as a Clinical Research Associate. Subsequently, Nasser worked at Genentech as a Project Coordinator/Manager in 2005.

Nasser then took on roles at the Immune Tolerance Network, starting as a Manager of Clinical Operations from 2005 to 2008, and later becoming the Associate Director of Clinical Operations from 2008 to 2010. From 2010 to 2013, Nasser worked at the UCSF Clinical & Translational Science Institute, first as a Director of Participant Recruitment Service and later as the Senior Director of Participant Recruitment & Study Management Services.

In 2013, Nasser founded Only For Good, an organization that is currently ongoing. Additionally, Nasser joined Roche in 2013 as a Digital Strategist until 2015. From 2015 to 2016, Nasser worked as the Global Head of Operational Innovation at Roche.

Since 2016, Nasser has been employed at Continuum Clinical. From 2016 to 2021, Nasser served as the Vice President of Global Site Solutions. In 2021, Nasser was promoted to Senior Vice President of Global Site Solutions. Then, in June 2022, Nasser took on the role of Executive Vice President of Product & Partnership Solutions, which is the most recent position held.

Nariman Nasser obtained a Bachelor of Science degree in Microbiology and Immunology from Arizona State University, completing the program from 1992 to 1996. Beyond this degree, Nariman has also received certification as a Certified Clinical Research Professional from the Society of Clinical Research Associates, although the specific month and year of obtaining this certification are not provided.